Analysis

Kaneka Corporation (4118) Stock Analysis

Kaneka Corporation investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to 4118.

website4118/analysis/4118

Kaneka Corporation

Kaneka Corporation investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to 4118.

Stock profile

Ticker

4118

Asset type

Stock

Market cap

$2.14B

Sector

Process Industries

Industry

Chemicals: Specialty

Currency

JPY

Ticker listings

Kaneka Corporation may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

4118 primary listing
KANKF
857863
KKA

Latest Kaneka Corporation news

Kaneka Ubiquinol™ Wins Coveted Vitafoods Europe Innovation Award 2026 in Partnership with Eqology

Kaneka Ubiquinol™, the sole global innovative manufacturer and pioneer of Ubiquinol, and inaugural Mitochondrial Health Category Sponsor at Vitafoods Europe 2026, announced toda...

Toro Neurovascular Announces FDA 510(k) Clearance for Toro 88 Superbore Catheter

First clinical cases successfully completed; U.S. launch to be led by Kaneka’s Neurovascular divisionIRVINE, Calif., March 11, 2026 (GLOBE NEWSWIRE) -- Toro Neurovascular today ...

Kaneka : Financial Summary for the Nine Months Ended December 31, 2025

Kaneka : Financial Summary for the Nine Months Ended December 31,

Kaneka Nutrients Expands Market Surveillance Efforts in Next Release of Ubiquinol Authenticity Testing

Kaneka Nutrients is advancing its efforts to monitor Ubiquinol product authenticity in response to growing concerns about misleading label claims. As the trusted leader in Ubiqu...

Kaneka : Signs Business Transfer Agreement for Zeon Corporation’s Medical Device Business

Kaneka : Signs Business Transfer Agreement for Zeon Corporation’s Medical Device

Kaneka Corporation (4118) Stock Analysis